QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

KMDA

QT62Kamada Ltd.
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic·IL
Latest market price
7.31
+0.05+0.69%
OverviewShort InterestFilings
KMDAQT62Kamada Ltd.·NASDAQ
OverviewShort InterestFilings
7.31+0.69%
TA
Loading chart...
Screen all →
TAK+1.36%$15.63HLN+1.01%$8.96TEVA-3.32%$31.48VTRS-2.29%$15.37ELAN+3.55%$24.22RDY+1.06%$13.29RGC-18.96%$12.01LNTH+0.65%$103.86
Snapshot
Index-P/E21.04EPS (ttm)
0.35
Insider Own0.49%
Shs Outstand57.68M
Perf Week-1.75%
Market Cap418.80MForward P/E11.92EPS next Y0.61Insider Trans0.00%Shs Float-Perf Month-3.82%
Enterprise Value397.52MPEG1.02EPS next Q0.12Inst Own-Short Float-Perf Quarter-15.20%
Income19.89MP/S2.31EPS this Y22.14%Inst Trans-Short Ratio-Perf Half Y2.67%
Sales181.68MP/B1.65EPS next Y43.47%ROA5.32%Short Interest-Perf YTD3.54%
Book/sh4.49P/C16.51EPS next 5Y17.68%ROE7.73%52W High9.35 -21.82%Perf Year2.38%
Cash/sh1.27P/FCF25.34EPS past 3/5Y-ROIC7.14%52W Low6.50 12.46%Perf 3Y-
Dividend Est.0.25 (3.42%)EV/EBITDA10.39Sales past 3/5Y11.74% 6.24%Gross Margin41.16%Volatility1.34% 1.77%Perf 5Y-
Dividend TTM0.25 (3.42%)EV/Sales2.19EPS Y/Y TTM40.00%Oper. Margin13.98%ATR (14)0.18Perf 10Y-
Dividend Ex-DateMar 23, 2026Quick Ratio1.90Sales Y/Y TTM13.04%Profit Margin11.21%RSI (14)38.45Recom2.17
Dividend Gr. 3/5Y-Current Ratio3.33EPS Q/Q0.00%SMA20-2.83%Beta1.24Target Price11.00
Payout55.45%Debt/Eq0.04Sales Q/Q2.27%SMA50-7.94%Rel Volume0.53Prev Close7.26
Employees420LT Debt/Eq0.03EarningsAug 12SMA200-4.71%Avg Volume47.03KPrice7.31
IPO DateMay 31, 2013Option/ShortYes / YesEPS/Sales Surpr.-41.67% -4.26%Net Debt/EBITDA-0.56Volume25,146Change0.69%
Analyst Ratings
DateActionAnalystRatingTarget
Mar-11-26ReiteratedStifel Nicolaus$20 → $11
Dec-09-25ReiteratedH.C. Wainwright$11 → $13
Nov-13-24ReiteratedStifel Nicolaus$20
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue182180161
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A10710491
Gross Profit757670
Selling, General and Administrative Excl. Other353431
Research and Development111315
Other Operating Expense334
Operating Income262620
Interest Expense011
Unusual Expense
———
Non-Operating Income (Expense)226
Net Income Before Taxes222313
Income Taxes13-1
Consolidated Net Income202014
Net Income From Continuing Operations202014
Net Income202014
EPS (Recurring)0.350.380.25
EPS (Basic, Before Extraordinaries)0.350.380.25
EPS (Diluted)0.350.370.25
EBITDA383928
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio20.8919.08—
Price To Sales Ratio2.372.27—
Gross Margin41.2142.2243.48
Operating Margin14.2914.4412.42
Net Margin10.9911.118.70
Shares Outstanding595857
Market Capitalization431409—
Operating Lease Expense
———
Insider Trading Volume
$7.80$7.26$6.71$6.17$5.63● Close Price0.00K0.00K0.00K0.00K0.00KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR